middle.news
Avecho Boosts Trial Momentum with $2.5M Raise Ahead of Key CBD Insomnia Data
1:12pm on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
Avecho Boosts Trial Momentum with $2.5M Raise Ahead of Key CBD Insomnia Data
1:12pm on Friday 31st of October, 2025 AEDT
Key Points
160 patients dosed in Phase III CBD TPM insomnia trial
Recruitment slowed temporarily due to seasonal illnesses but has normalized
$2.5 million capital raise completed post-quarter
Preparations underway for TGA submission anticipated in H1 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE